ImageQuant™ 800 for lateral flow assay development using dyes across the spectrum
4 Jan 2022The development of assays based on lateral flow has led to low cost and effective large-scale screening of infectious diseases with high specificity. Lateral flow assays consist of membranes, antibodies, and reagents for the detection of a color change or fluorescent dye. Lateral flow assays are an area of intense research and have led to highly robust and sensitive products, including a range of Whatman™ diagnostic solutions from Cytiva. In this application note, Cytiva investigate the use of Conjugated Polymer Nanoparticles (CPNs™) Amersham™ ImageQuant™ 800 systems for lateral flow assays and Western Blotting.
Related Products
Request Quote for All Products
Amersham ImageQuant 800 systems
CytivaFlexible imagers with automated features for sensitive, accurate chemiluminescence and fluorescence detection. To support your electronic data management, an optional GxP module is available, designed to meet increasing requirements of regulations like FDA 21 CFR part 11 and EU GMP Annex 11.